Clinical Trials Directory

Trials / Completed

CompletedNCT01185002

Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Medtronic - MITG · Industry
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to test the effect of a bowel preparation and boosts regimen on PillCam® procedure, colon cleanliness and capsule excretion time.

Detailed description

Interim analysis will be done after 20 subjects are enrolled in order to assess the 1st arm. Following the analysis of the first phase results, and per need, 30 more subjects may be enrolled under a different regimen (2nd arm). Second Interim analysis will be done in order to assess the 2nd phase results. Following the analysis of the 2nd phase results, and per need, up to 30 additional subjects may be enrolled under a third regimen (3rd arm).

Conditions

Interventions

TypeNameDescription
OTHERPillCam® COLON 2 procedure using MgC boostsSubjects will be instructed to perform the colon preparation procedure and follow a detailed dietary regimen prior to and during the CE procedure. During the CE procedure the subjects will be required to take MgC boosts.
OTHERPillCam® COLON 2 procedure using Suprep boostsSubjects will be instructed to perform the colon preparation procedure and follow a detailed dietary regimen prior to and during the CE procedure. During the CE procedure the subjects will be required to take Suprep boosts
OTHERPillCam® COLON 2 procedure using reduced dose of Suprep boostsSubjects will be instructed to perform the colon preparation procedure and follow a detailed dietary regimen prior to and during the CE procedure. During the CE procedure the subjects will be required to take reduced dose of Suprep boosts

Timeline

Start date
2010-07-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2010-08-19
Last updated
2019-07-31

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01185002. Inclusion in this directory is not an endorsement.